MYRIAD GENETICS INC (MYGN)
Sector: Health Care
Sector: Health Care
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Brian J. Donnelly Chief Commercial Officer | 2025 | $350,000 | $450,000 | $4,801,898 | $0 | $371,910 | $26,337 | $6,000,145 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Samraat S. Raha President and Chief Executive Officer | 2025 | $856,901 | $0 | $3,989,729 | $0 | $814,660 | $25,450 | $5,686,740 |
| 2024 | $750,000 | $0 | $2,910,681 | $0 | $706,500 | $22,146 | $4,389,327 | |
| 2023 | $14,368 | $500,000 | $4,502,658 | $0 | $0 | $390 | $5,017,416 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Mark S. Verratti Chief Operating Officer | 2025 | $622,883 | $0 | $2,058,069 | $0 | $438,323 | $25,976 | $3,145,251 |
| 2024 | $552,344 | $0 | $2,646,082 | $0 | $489,720 | $24,072 | $3,712,217 | |
| 2023 | $495,781 | $0 | $1,959,282 | $0 | $400,247 | $19,779 | $2,875,089 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Scott J. Leffler Former Chief Financial Officer | 2025 | $393,798 | $0 | $1,067,674 | $0 | $0 | $1,275,021 | $2,736,493 |
| 2024 | $487,572 | $400,000 | $4,792,601 | $0 | $428,539 | $44,458 | $6,153,170 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Margaret Ancona Former EVP, Strategy and Transformation | 2025 | $330,850 | $0 | $800,754 | $0 | $0 | $763,561 | $1,895,166 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Dale Muzzey, Ph.D. Chief Scientific Officer | 2025 | $506,400 | $0 | $1,121,054 | $0 | $221,677 | $13,781 | $1,862,912 |
| 2024 | $499,350 | $0 | $2,222,701 | $0 | $265,100 | $18,727 | $3,005,878 | |
| 2023 | $443,750 | $111,039 | $1,415,045 | $0 | $250,650 | $11,066 | $2,231,550 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Benjamin R. Wheeler Chief Financial Officer | 2025 | $408,493 | $0 | $759,229 | $0 | $325,421 | $14,754 | $1,507,897 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Paul J. Diaz Former President and Chief Executive Officer | 2025 | $418,103 | $0 | $0 | $0 | $0 | $270,534 | $688,637 |
| 2024 | $1,120,875 | $0 | $11,113,514 | $0 | $1,356,750 | $39,461 | $13,630,599 | |
| 2023 | $1,086,750 | $0 | $9,796,451 | $0 | $1,168,440 | $56,718 | $12,108,359 |